| Sanofi-Aventis (Suisse) SA - Aubagio 14 mg QOD, comprimés pelliculés | | 62761 | | 02 | | Aubagio 14 mg QOD | | comprimés pelliculés | | L04AA31 | | Teriflunomide | | 17.12.2021 | | |
| | Composition | | Comprimé pelliculé: teriflunomidum 14 mg, lactosum monohydricum 76 mg, maydis amylum, hydroxypropylcellulosum, cellulosum microcristallinum, carboxymethylamylum natricum A, magnesii stearas, pellicule: hypromellosum, talcum, macrogolum, E 132, E 171, pro compresso obducto corresp. natrium 1.75 mg. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose | additional_information |
|---|
| | 14 mg | Comprimé pelliculé |
| | BAG: Active Agent | Dose |
|---|
| | 14 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | | | | | | | | | color. | | | | color. | | | | | | Hypromellosum | | pellicule | | Lactose Monohydrate | 76 mg | | | Macrogol | | | | | | | | | | | | | | | | Talcum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 006 | 28 | 549.19 | 603.55 | B | SL | No |
|
|
